Health care analysts predict the global hepatitis diagnostics market will reach up to $6.9 billion by 2025, a recent press release from Grand View Research reports.
The growth is attributable to a rapid rise in testing, awareness
Key findings from the report suggest hepatitis blood tests will dominate the market and see the fastest growth, thanks to their growing adoption as
Last year, North America represented the largest hepatitis diagnostic market, owing to rising prevalence, heightened awareness and a developed
Major players in the arena will likely include Abbott Laboratories, Roche,